首页>
外国专利>
ANTISENSE OLIGONUCLEOTIDES AGAINST NEUTRAL SPHINGOMYELINASE AND NEUTRAL SPHINGOMYELINASE INHIBITOR GW4869 FOR DEGENERATIVE NEUROLOGICAL DISORDERS
ANTISENSE OLIGONUCLEOTIDES AGAINST NEUTRAL SPHINGOMYELINASE AND NEUTRAL SPHINGOMYELINASE INHIBITOR GW4869 FOR DEGENERATIVE NEUROLOGICAL DISORDERS
展开▼
机译:抗中性神经鞘脂酶和中性神经鞘脂酶抑制剂GW4869的抗衰老神经退行性疾病
展开▼
页面导航
摘要
著录项
相似文献
摘要
Alzheimer's disease (AD) is the most common human neurodegenerative disease of the CNS resulting in progressive neuronal death and memory loss. Despite intense investigations, no effective therapy is available to stop its onset or halt its progression. It was discovered that antisense oligonucleotide against neutral sphingomyelinase and GW4869, a chemical inhibitor of neutral sphingomyelinase, inhibit activation of glial cells and protect neurons in AD cell culture and animal models. These results suggest the following new treatment options for AD patients: Antisense oligonucleotide against neutral sphingomyelinase and GW4869.
展开▼